Limoneira Company (LMNR)

$AVO vs. $LMNR — Which fresh produce play has the better growth recipe? 🥑🍋 AVO leans on global scale, tech, and diversification, while LMNR bets on land, citrus, and real estate to drive long-term upside. Full comparison here 👉 https://www.zacks.com/stock/news/2496438/mission-produce-vs-limoneira-which-stock-is-a-better-fresh-food-bet?cid=sm-stocktwits-2-2496438-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2496438_TEASER

$AVO vs. $LMNR: Which produce powerhouse is set to thrive? Mission Produce shines with a 28% revenue boost, driven by strong pricing and global reach, while Limoneira experiences a 21% revenue drop but aims to improve efficiency with its Sunkist partnership. AVO's stock also outperformed with a 16% return vs. LMNR's 15.2% decline. Discover the full investment case here 👉 https://www.zacks.com/commentary/2496438/mission-produce-vs-limoneira-which-stock-is-a-better-fresh-food-bet?cid=sm-stocktwits-2-2496438-body&ADID=SYND_STOCKTWITS_TWEET_2_2496438_BODY

$LMNR Smoking skyward.

Lake Street has adjusted their stance on Limoneira ( $LMNR ), setting the rating to Buy with a target price of 23.

$LMNR (-4.5% pre) Limoneira Reports Q2 2025 Results and Strategic Merger https://ooc.bz/l/67484

Gapping Down: $LAKE -18% $AIRS -14.1% $CVGW -12% $ONDS -11.9% $LMNR -10.4%

$LMNR incompetent management

$LMNR reported -0.17 EPS and 35.12 revenue for Q2. http://www.estimize.com/intro/lmnr?chart=historical&metric_name=eps&utm_content=LMNR&utm

$LMNR welcome to VITL

$LMNR light volume, emotional trading, it will be green on guidance tomorrow

$LMNR Limoneira still sees strong EBITDA outlook, to expand avocado production Limoneira said, "The Company now expects fresh lemon volumes to be in the range of 4.5 million to 5.0 million cartons for fiscal year 2025. The Company continues to expect avocado volumes to be in the range of 7.0 million to 8.0 million pounds for fiscal year 2025. The Company expects to receive total proceeds of approximately $180 million from Harvest, LLCB II, LLC and East Area II spread out over seven fiscal years, with approximately $10 million received in April 2025 and $15 million received in fiscal year 2024. The Company has 700 acres of non-bearing avocados estimated to become full bearing over the next four to five years, which the Company expects will enable strong organic growth in the coming years. Additionally, the Company plans to continue expanding its plantings of avocados over three years. The foregoing describes organic growth opportunities and does not include potential acquisition opportunities for the Company in its highly fragmented industry. Looking ahead, we continue to see a strong EBITDA outlook that is underpinned by plans to expand avocado production by an additional 500 acres through fiscal year 2027 to capitalize on expected robust consumer demand trends. During this transition, the Company expects fiscal year 2025 avocado volume to be lower compared to fiscal year 2024 due to the alternate bearing nature of avocado trees. These operational results do not take into account anticipated additional gains from asset monetization."

$LMNR Limoneira reports Q2 adjusted EPS (17c), two estimates (1c) Reports Q2 revenue $35.1M, two estimates $38.7M. Harold Edwards, President and Chief Executive Officer of the Company, stated, "The oversupplied lemon market created pricing pressure in our second quarter, yet we delivered strong results across our other business lines. Our avocado operations benefited from robust pricing that continued throughout the quarter, and we expect strong results in the third quarter when the majority of our harvest occurs. Our real estate development project, Harvest at Limoneira, maintained strong home sales velocity, which could potentially accelerate the timing of Phase 3, and we remain on track to close two additional water monetization transactions this fiscal year."

$LMNR Limoneira to merge citrus sales, marketing operations with Sunkist Growers Limoneira Company announced a strategic merger of its citrus sales and marketing operations with Sunkist Growers. Beginning in the first quarter of fiscal year 2026, Limoneira will return to Sunkist as one of their largest lemon growers and an exclusive Sunkist private licensed packer. This strategic reunion is expected to generate $5M in annual cost savings and EBITDA improvement starting in fiscal year 2026 through planned streamlined operations and enhanced supply chain efficiency. Under the new agreement, Limoneira's sales and marketing team will transition to Sunkist, creating operational synergies through shared storage, washing, and packing capabilities across the Sunkist network. Harold Edwards, President and Chief Executive Officer of Limoneira, stated, "This strategic partnership represents a transformative moment in the citrus industry, combining two pioneering organizations to create an unmatched market presence. By uniting Limoneira's operational excellence with Sunkist's comprehensive distribution network and brand power, we are creating an industry-leading platform that strives to drive significant value for our customers, growers, and shareholders. Together, we plan to deliver reliable supply, operational efficiency, and complete category coverage to the nation's premier food service and retail customers, while generating meaningful cost savings and establishing a stronger foundation for sustainable growth." The transaction is expected to close on November 1, 2025.

$CASY $CVGW $LMNR $LAKE $SKIL

#earnings after the close on Monday, June 9, 2025 and before the open on Tuesday, June 10, 2025 https://www.earningswhispers.com/calendar $CASY $CVGW $ASO $UNFI $LMNR

Today's earnings after the close: $CASY $CVGW $LMNR $LAKE $SKIL Check out the rest of the list here: https://stockanalysis.com/stocks/earnings-calendar/?ref=saveontrading

Notable companies due to report include: Casey's General Stores $CASY, Calavo Growers $CVGW, Limoneira $LMNR and Lakeland Industries $LAKE 🔔

$LMNR VITL

Heads up alert! upcoming earnings on Monday, 6/9/2025 for $LMNR Bearish (2.5) Limoneira Company (NASDAQ: LMNR) operates in the citrus growing and agribusiness sector, and recent performance indicators suggest a challenging environment for the stock. Over the past few months, LMNR's share price has experienced a decline, reflecting broader market sentiments and specific company challenges. The most recent analysis indicates that Limoneira is currently undervalued by approximately 46%, with an intrinsic valuation pegged at $29.86 based on a two-stage free cash flow model. Despite this potential upside, the company's trailing twelve-month (TTM) P/E ratio remains elevated compared to industry peers, casting doubts on its near-term growth prospects. Furthermore, the compound annual growth rate (CAGR) for shareholders over the last three years stands at 15%, suggesting some resilience, yet this figure has been overshadowed by recent price declines. Revenue forecasts appear cautious, pointing to potential headwinds in the citrus market, while options market volatility indicates heightened investor uncertainty. In terms of upcoming earnings reports, Limoneira is scheduled to announce its second-quarter financial results on June 9, 2025. Analysts are closely monitoring this release, as it will provide crucial insights into the company’s operational health and profitability. Historical performance has shown fluctuations in earnings, and with the market anticipating a detailed breakdown of revenue streams and cost management, any significant deviation from analyst consensus estimates could impact stock performance considerably. Current analyst estimates remain conservative, reflecting a cautious outlook on revenue and earnings per share (EPS) growth given the current industry dynamics. The agricultural sector, particularly citrus, has faced its own set of challenges, including climate variability and fluctuating demand. These factors have generally placed pressures on pricing and profitability across the board, indicating a sector-wide trend that could further influence Limoneira's stock trajectory. The current economic climate, characterized by increasing interest rates and market volatility, adds another layer of complexity, potentially affecting investor sentiment and market positioning for companies within this space. Overall, while there may be long-term growth potential, the immediate outlook for Limoneira appears bearish amid economic uncertainties. - Funds were net buyers of $LMNR during the previous reporting quarter. - Top 1 funds with large holdings in $LMNR: - Old West Invest, MV: $8MM. Fund Rank: 69% www.oldwestim.com - Last 10 days performance: -2% - Last 30 days performance: -3% - Last 90 days performance: -31% Some of the latest news articles: - Title: Limoneira to Announce Second Quarter 2025 Financial Results on June 9, 2025 Publication Date: 5/27/2025 12:30:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/limoneira-announce-second-quarter-2025-123000441.html?.tsrc=rss - Title: US Market's Hidden Gems: Discover 3 Small Cap Stocks with Strong Fundamentals Publication Date: 5/21/2025 5:34:10 PM, Source: yahoo URL: https://finance.yahoo.com/news/us-markets-hidden-gems-discover-173410868.html?.tsrc=rss - Title: Limoneira (NASDAQ:LMNR) shareholders have earned a 15% CAGR over the last three years Publication Date: 5/20/2025 11:34:53 AM, Source: yahoo URL: https://finance.yahoo.com/news/limoneira-nasdaq-lmnr-shareholders-earned-113453516.html?.tsrc=rss - Title: Implied Volatility Surging for Limoneira Stock Options Publication Date: 4/30/2025 3:15:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/implied-volatility-surging-limoneira-stock-151500939.html?.tsrc=rss Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.

Wall St is expecting -0.01 EPS for $LMNR Q2 [Reporting 06/10 AMC] http://www.estimize.com/intro/lmnr?chart=historical&metric_name=eps&utm_c

🚨🚨 WAKE UP — this setup is getting too obvious to ignore! 🚨🚨 We’re sitting near $3.10, and the 1-year analyst price target is $16.00 — that’s a projected +416% upside 📈 Rating? Strong Buy — no confusion, no debate. This is a conviction play. Last week’s move was just the beginning — we’re hearing high-confidence info from private sources: ⚠️ Major upside expected early next week — 100%+ move very much in play. And yes, the sources are legit. Microfloat, FDA catalyst, confirmed revenue, big-name partners (Thermo Fisher, Quest), and now? 📊 Analyst targets that scream undervalued. 🦍 I’m calling all $LMNR , $ROST apes — you’ve seen what coordinated action can do. Hold off and drop your orders together — coordinated buys = max impact 💥 Let’s ignite this. Eyes on the breakout. Next week won’t wait. 🔥🚀 Not financial advice. But ignoring this? Might cost more than missing a trade.⁩